TRCT
CANO

Tower Research Capital (TRC)’s Cano Health, Inc. CANO Stock Holding History

Tower Research Capital (TRC)’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,396
Closed -$14.1K – 6351
2023
Q4 		$14.1K Buy
2,396
+1,645
+219% +$19.5K ﹤0.01% 3910
2023
Q3 		$19.1K Buy
751
+701
+1,402% +$57.6K ﹤0.01% 3420
2023
Q2 		$6.95K Sell
50
-82
-62% -$10.5K ﹤0.01% 4640
2023
Q1 		$12K Buy
132
+63
+91% +$8.55K ﹤0.01% 4155
2022
Q4 		$9K Sell
69
-45
-39% -$15.2K ﹤0.01% 4325
2022
Q3 		$98K Sell
114
-193
-63% -$121K ﹤0.01% 2581
2022
Q2 		$135K Buy
307
+187
+156% +$97.5K ﹤0.01% 2062
2022
Q1 		$76K Buy
120
+34
+40% +$21.4K ﹤0.01% 2401
2021
Q4 		$76K Buy
86
+22
+34% +$23.1K ﹤0.01% 2430
2021
Q3 		$81K Sell
64
-35
-35% -$42.4K ﹤0.01% 2584
2021
Q2 		$120K Buy
99
+85
+607% +$115K ﹤0.01% 2286
2021
Q1 		$19K Buy
14
+13
+1,300% +$18.4K ﹤0.01% 3939
2020
Q4 		$2K Buy
+1
New +$1.14K ﹤0.01% 4939

Other funds holding CANO

SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GFPC
Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Tower Research Capital (TRC)'s CANO Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 2,396 shares — an estimated $14.1K sold.

Tower Research Capital (TRC) first reported a position in CANO in Q4 2020 and held it in 13 quarters. The position peaked at $135K in Q2 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Tower Research Capital (TRC) reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,396 Cano Health, Inc. shares in Q1 2024, an estimated $14.1K.
  • Tower Research Capital (TRC) first reported a position in Cano Health, Inc. in Q4 2020 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s Cano Health, Inc. position peaked at $135K in Q2 2022.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.